<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Form 8-K - Current report</title>
<style>
body { font-family: Arial, Helvetica, sans-serif; background:#0f1115; color:#e6e6e6; margin:0; padding:40px; }
.container { max-width:700px; margin:auto; background:#161a21; border-radius:10px; padding:32px; box-shadow:0 0 30px rgba(0,0,0,0.4); }
h1 { margin-top:0; color:#4da3ff; }
table { width:100%; margin-top:12px; border-collapse:collapse; }
th, td { text-align:left; padding:6px 8px; border-bottom:1px solid #2a2f3a; }
ul { margin-top:12px; padding-left:20px; }
.section { margin-top:24px; }
.small { margin-top:12px; font-size:13px; color:#999; }
a { color:#4da3ff; }
</style>
</head>
<body>
  <div class="container">
    <h1>Form 8-K - Current report</h1>

    <table>
      <tr><th>Ticker</th><td>ELAB</td></tr>
      <tr><th>Float</th><td>1.1 M</td></tr>
      <tr><th>IO</th><td>0.05%</td></tr>
      <tr><th>MC</th><td>2.0 M</td></tr>
      <tr><th>Extra Info</th><td>None</td></tr>
    </table>

    <div class="section">
      <strong>Summary</strong>
      <p>PMGC Holdings Inc. (CIK 0001840563) filed a Current Report on Form 8-K on February 10, 2026 (period of report February 4, 2026) reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 9.01 (Financial Statements and Exhibits). The filing includes an Exhibit 10.1 titled “License Agreement between Northstrive Biosciences Inc. and Modulant Biosciences.” The index lists the primary 8-K HTML document and the license agreement exhibit; the index provides company contact and address information but does not present transaction financial terms in the index itself.</p>
    </div>

    <div class="section">
      <strong>Positives</strong>
      <ul><li>Company disclosed entry into a material definitive agreement via Form 8-K.</li><li>License agreement between Northstrive Biosciences Inc. and Modulant Biosciences is filed as Exhibit 10.1.</li><li>Filing follows SEC disclosure requirements (Items 1.01 and 9.01).</li></ul>
    </div>

    <div class="section">
      <strong>Negatives</strong>
      <ul><li>Index does not disclose financial terms, consideration, or specific economic impact of the agreement.</li><li>No summary of operational or financial effects provided in the index entry; need to open the primary 8-K and Exhibit 10.1 for details.</li></ul>
    </div>

    <div class="section">
      <a href="https://www.sec.gov/Archives/edgar/data/1840563/000121390026014285/0001213900-26-014285-index.htm" target="_blank">Original Article</a>
    </div>

    <div class="small">ELAB • TradersLink AI News</div>
  </div>
</body>
</html>